Kimberly-Clark Corp (KMB.N)

KMB.N on New York Stock Exchange

117.77USD
24 Dec 2014
Price Change (% chg)

$-0.21 (-0.18%)
Prev Close
$117.98
Open
$118.24
Day's High
$118.67
Day's Low
$117.77
Volume
241,417
Avg. Vol
421,279
52-wk High
$118.67
52-wk Low
$98.78

KMB.N

Chart for KMB.N

About

Kimberly-Clark Corporation is engaged in the manufacturing and marketing of a range of products made from natural or synthetic fibers. The Company operates in four segments Personal Care, Consumer Tissue, K-C Professional and HealthCare. The Company operates and markets its products globally in Asia, Latin America, Eastern... (more)

Overall

Beta: 0.21
Market Cap (Mil.): $43,864.05
Shares Outstanding (Mil.): 372.46
Dividend: 0.84
Yield (%): 2.85

Financials

  KMB.N Industry Sector
P/E (TTM): 20.85 60.82 34.05
EPS (TTM): 5.65 -- --
ROI: 16.04 9.46 64.40
ROE: 48.10 11.45 72.71
Search Stocks

Former Kimberly-Clark healthcare unit makes muted market debut

- Shares of Halyard Health Inc , the spun-off healthcare unit of Kimberly-Clark Corp , rose marginally in their market debut on Monday after many of the investors who expect the company to benefit from the Ebola crisis apparently bought the stock during its near two-week period of unofficial trading.

03 Nov 2014

UPDATE 1-Former Kimberly-Clark healthcare unit makes muted market debut

Nov 3 - Shares of Halyard Health Inc, the spun-off healthcare unit of Kimberly-Clark Corp, rose marginally in their market debut on Monday after many of the investors who expect the company to benefit from the Ebola crisis apparently bought the stock during its near two-week period of unofficial trading.

03 Nov 2014

REFILE-Former Kimberly-Clark healthcare unit makes muted market debut

Nov 3 - Shares of Halyard Health Inc, the spun-off healthcare unit of Kimberly-Clark Corp, rose marginally in their market debut on Monday after many of the investors who expect the company to benefit from the Ebola crisis apparently bought the stock during its near two-week period of unofficial trading.

03 Nov 2014

Halyard Health poised to shine in debut on back of Ebola scare

(This October 31st story corrects paragraph 4 to say "Existing Kimberly-Clark shareholders received one share of Halyard for every eight Kimberly-Clark shares held" from "...will be able to exchange eight shares of Kimberly-Clark for one share of Halyard".)

03 Nov 2014

CORRECTED-RPT-Halyard Health poised to shine in debut on back of Ebola scare

(Corrects paragraph 4 to say "Existing Kimberly-Clark shareholders received one share of Halyard for every eight Kimberly-Clark shares held" from "...will be able to exchange eight shares of Kimberly-Clark for one share of Halyard". The error also appeared in the original story.)

03 Nov 2014

Halyard Health poised to shine in debut on back of Ebola scare

Oct 31 - When Kimberly-Clark Corp decided a year ago to carve off its healthcare division, it probably did not envisage launching the company amid the deadliest ever outbreak of the Ebola virus.

31 Oct 2014

Kimberly-Clark faces $500 million suit over Ebola protection gown

- A Southern California law firm has sued Kimberly-Clark Corp for more than $500 million, alleging that the Kleenex tissue maker committed fraud by marketing and selling some of its surgical gowns as protection against Ebola.

30 Oct 2014

UPDATE 1-Kimberly-Clark faces $500 mln suit over Ebola protection gown

Oct 30 - A Southern California law firm has sued Kimberly-Clark Corp for more than $500 million, alleging that the Kleenex tissue maker committed fraud by marketing and selling some of its surgical gowns as protection against Ebola.

30 Oct 2014

Kimberly-Clark faces $500 mln lawsuit over Ebola protection gear

Oct 30 - A Southern California-based law firm has sued Kimberly-Clark Corp for more than $500 million, alleging that the Kleenex tissue maker committed fraud by marketing and selling some of its surgical gowns as protection against Ebola.

30 Oct 2014

UPDATE 2-Kimberly-Clark to cut up to 1,300 jobs after spinoff

* Shares rise 2 pct (Adds details, analyst comment, shares)

21 Oct 2014

Competitors

Earnings vs. Estimates

Analyst Research Reports

Report Title Price
Provider: Thomson Reuters Stock Report
$25.00
Provider: Stock Traders Daily
$20.00
Provider: New Constructs, LLC
$25.00
Provider: MacroRisk Analytics/EconomicInvestor
$25.00
Provider: Wright Reports
$75.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Search Stocks